Stem Cell Therapeutics
- TSX Venture
- Consumer Products
- Latest 0.65
- Currency C$
- Change 0.02
- Percent Change 3.175 %
- Volume 39,573
- Mon Mar 10, 2014 09:50 AM EDT TSX Venture data delayed 15 minutes.
12 months ended Dec 31, 2012.
Trailing 12 month results shown above.
All data is in Canadian dollars.
|Earnings||Nov 25||n/a||Apr 14||n/a|
12 months ended Mar 10, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
STEM CELL THERAPEUTICS CORP. is Canada's only public biopharmaceutical company dedicated to advancing cancer stem cell discoveries into novel and innovative cancer therapies. Company is supported by established links to a group of Toronto academic research institutes & cancer treatment centers, representing one of the world¿s most acclaimed cancer research huns.